| 11 | $TKOI News Article - Telkonet Signs Stock | whytestocks | 08/09/2021 10:00:45 AM |
| 10 | $TKOI News Article - Telkonet, Inc. and | whytestocks | 03/08/2021 8:50:47 AM |
| 9 | TKOI 32% v1,2M c.0379 f136M | znewcar1 | 11/27/2020 2:35:41 PM |
| 8 | Telkonet, Inc. (OTCQB: TKOI) has far bigger and | Uptick Network | 08/03/2016 1:42:35 PM |
| 7 | TKOI Financials 07/15/2014 23:06:09 Telkonet, | Emylers | 07/16/2014 12:06:06 AM |
| 6 | Glad you liked it. thanks | Stock_Tracker | 03/12/2014 8:50:57 PM |
| 5 | Nice post although there are a couple erroneous | littlbyrdy | 03/11/2014 8:58:33 PM |
| 4 | Latest Telkonet Inc (TKOI) Headlines Telkonet | Stock_Tracker | 03/11/2014 7:23:41 PM |
| 3 | TKOI 0.26 Stock Charts $TKOI 1 Month Chart | chartguy89 | 03/10/2014 6:20:51 AM |
| 2 | TKOI Stock Charts Last: +0.001 Sunday, March 2, | chartguy89 | 03/02/2014 12:31:31 AM |
| 1 | Do not overlook TELKONET ... | JCM | 03/24/2013 11:41:10 PM |
Recent Articles
- Secure Your Rights: Join the Avantor, Inc. Class Action
- Latest Updates on Caribou Biosciences' CAR-T Cell Trials
- How Tanka's AI Platform is Shaping the Future of Startups
- Caribou Biosciences Announces Upcoming Webcast for CAR-T Data
- Kevin O'Leary's Journey: Overcoming Failures to Find Freedom
- The Secrets Behind A $6.5 Million Used Clothing Business Success
- Important Legal Update for Tronox Investors: Act Now
- Class Action Alert: Quantum Corporation Stockholder News
- Warren Buffett's Reflective Lessons from Investment Mistakes
- Transforming Housekeeping into a Lucrative Career Path
- Apple's Strategic Innovations and Market Challenges Ahead
- Snowflake's Mike Gannon Sparks SEC Filing After Influencer Talk
- Livestrong Foundation's Annual Challenge Empowers Cancer Survivors
- Google's Decision to Shift Women Techmakers Program Sparks Controversy
- Podiatry Content Connection Unveils Innovative AI Solutions
- zerohash Europe Gets MiCAR Authorization for Crypto Services
- Tech Titans' Dinner Sparks Fried Chicken Stock Boom
- The Rise of the Silver American Eagle: Why Stackers Are Going All In
- Tenaris Launches $600 Million in Share Buyback for Investors
- Kiyosaki Advocates for Bitcoin and Ethereum Amid Market Uncertainty
- Tenaris Launches $600 Million in Share Buybacks Amid Growth
- Exploring AI Adoption Among Small Businesses Across The U.S.
- Shiba Inu ETF Filing Sparks Significant Token Burn Event
- Investors of Avantor, Inc. Encouraged to Seek Justice Together
- Al Salam Bank Commemorates ASB Capital's Successful Year
- Tom Lee: The Trusted Face of Ethereum in the Finance World
- Elon Musk and Sam Altman: The Roadster Refund Debate
- Navigating Career Transitions: Insights from Industry Experts
- Key Steps for Fortinet, Inc. Investors Ahead of Class Action
- Air Traffic Controllers Face Staffing Crisis Amid Shutdown
- Warren Challenges Trump on Rising Costs Affecting Families
- James Hardie Industries Investors Invited to Join Critical Lawsuit
- Fluor Corporation's Investors Encouraged to Act Now for Justice
- Bitcoin Surges to $100K Amidst Market Challenges and Insights
- Ziegler Successfully Completes $44M Financing for Frasier
- Lowe's Contributes $1 Million for Hurricane Recovery in Jamaica
- Celebrate Dodgers' Triumph with New Era's 2025 Collection
- Richmond Terrace Capital Launches New €1.5 Billion Investment Fund
- Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing
- Sequoia Capital Launches $950M Fund to Fuel AI Innovators
- Virginia Veterans Celebrate with Free Book Vouchers for Stories
- Innovative Advancements of Poain BlockEnergy in Global DeFi Market
- Investors of aTyr Pharma Should Secure Legal Help Now
- Bahrain Premieres Revolutionary Rooftop Solar Power Initiative
- Deqing's Pearl Mussel Award: A Mark of Agricultural Heritage
- Buck Sexton Unveils the Dawn of America’s Next Wealth Era
- Navigating the Promising Journey of Mutuum Finance and MUTM
- Belite Bio's Conditional Marketing Authorization Success for Tinlarebant
- Top Large-Cap Movers: Teradyne, Wayfair, and More Insights
- Top Stock Insights: Palantir's Surge and Pfizer's Struggles
